Keywords
Opioid-related disorders
Emergency service hospital
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the management and prevention of opioid intoxication syndrome in the emergency room. Literature review: Opioids are essential drugs in the treatment of moderate to severe pain and have a potent analgesic effect. Despite this, these drugs can cause some serious side effects that compromise the patient's general well-being. In addition, inappropriate prescription can generate chemical dependence and withdrawal syndrome. Naloxone was the most widely used drug to reverse opioid intoxication, which was developed in the 1960s and was the first opioid receptor antagonist to reduce the clinical symptom of induced respiratory depression, without producing receptor agonist effects. Final considerations: Naloxone is an effective drug for the management of opioid intoxication in the current drug treatment. Furthermore, the preoperative preventive approach is an efficient approach to avoid possible opioid intoxication resulting from the incorrect use, dependence or abuse of opioids formally prescribed by doctors.
References
ALGERA MH, et al. Opioid-induced Respiratory Depression in humans: a Review of Pharmacokinetic–pharmacodynamic Modelling of Reversal. British Journal of Anaesthesia, 2019; 122(6): 168–179.
BATEMAN JT, SAUNDERS, SE, LEVITT, ES. Understanding and countering opioid-induced respiratory depression. British Journal of Pharmacology, 2021; 180(7): 813–828.
BAUD FJ. Étude du mécanisme des overdoses aux opioïdes: apport de l’expérimental à la clinique. Annales Pharmaceutiques Françaises, 2009; 67(5): 353–359.
BLACKWOOD CA, CADET JL. The molecular neurobiology and neuropathology of opioid use disorder. Current Research in Neurobiology, 2021; 2(2): 100023.
BRITCH, SC. WALSH, SL. Treatment of opioid overdose: current approaches and recent advances. Psychopharmacology, 2022; 239(7): 2063-2081.
CAO D, et al. “Insights into the Mechanisms Underlying Opioid Use Disorder and Potential Treatment Strategies”. British Journal of Pharmacology, 2023, 180(7): 862–878.
DEGENHARDT L, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. The Lancet, 2019, 394(10208): 1560-1579.
GOMEZESE OF, SEIJA D, VIVAS SM, et al. Recomendaciones para la prescripción segura de opioides en pacientes con historia o riesgo de abuso. Revista de la Sociedad Española del Dolor, 2022; 28(6): 343-349.
LEMEN PM, et al. High-dose naloxone formulations are not as essential as we thought. Harm Reduction Journal, 2024; 21(1): 93.
MAIA LO, et al. Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators. Substance Abuse Treatment, Prevention, and Policy, 2021; 16(1): 12-22.
PASHA AK, et al. “Substance Use Disorders: Diagnosis and Management for Hospitalists.” Journal of Community Hospital Internal Medicine Perspectives, 2020; 10(2): 117–126.
RIBERO OFG, et al. Recomendaciones para la prescripción segura de opioides en pacientes con historia o riesgo de abuso. Revista de la Sociedad Española del Dolor, 2021; 28: 343–49.
RUCINSKI K, COOK JL. Effects of preoperative opioid education on postoperative opioid use and pain management in orthopaedics: a systematic review. Journal of orthopaedics, 2020; 20: 154-159.
SAARI TI, et al. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone. Clinical Pharmacokinetics, 2024; 63(4): 397-422.
SKOLNICK P. Treatment of overdose in the synthetic opioid era. Pharmacology & Therapeutics, 2022; 233: 108019.
STAHL SM. Stahl psicofarmacologia: bases neurocientíficas e aplicações práticas. 5a ed. Rio de Janeiro: Guanabara Koogan. 2022.
TRESCOT AM, et al. Opioid pharmacology. Pain Physician, 2008; 11: 133-153.
VAN DRAANEN J, et al. Socioeconomic marginalization and opioid-related overdose: A systematic review. Drug and Alcohol Dependence, 2020; 214: 108127.
VOEPEL-LEWIS T, et al. A risk education program decreases leftover prescription opioid retention: an RCT. American journal of preventive medicine, 2022; 63(4): 564-573.